Compare SIBN & ETW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIBN | ETW |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 886.9M | 1.0B |
| IPO Year | 2018 | N/A |
| Metric | SIBN | ETW |
|---|---|---|
| Price | $17.48 | $9.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $25.57 | N/A |
| AVG Volume (30 Days) | ★ 533.2K | 284.6K |
| Earning Date | 02-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $193,578,000.00 | N/A |
| Revenue This Year | $21.44 | N/A |
| Revenue Next Year | $15.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.27 | N/A |
| 52 Week Low | $12.50 | $6.96 |
| 52 Week High | $21.89 | $8.49 |
| Indicator | SIBN | ETW |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 58.95 |
| Support Level | $17.01 | $9.23 |
| Resistance Level | $21.89 | $9.38 |
| Average True Range (ATR) | 0.91 | 0.06 |
| MACD | -0.39 | 0.00 |
| Stochastic Oscillator | 8.82 | 72.76 |
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.